CLIONA ROONEY to Histocompatibility Antigens Class I
This is a "connection" page, showing publications CLIONA ROONEY has written about Histocompatibility Antigens Class I.
Connection Strength
0.321
-
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells. J Transl Med. 2019 07 24; 17(1):240.
Score: 0.159
-
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy. 2012 Oct; 14(9):1131-43.
Score: 0.098
-
Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med. 2004 Feb 16; 199(4):459-70.
Score: 0.054
-
Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. Hum Gene Ther. 1998 Jul 01; 9(10):1419-27.
Score: 0.009